Company: PCRX
Filing Date: 2025-01-30
Form Type: 8-K
Source: 0001396814-25-000022
Chunk: 1

Company: Pacira BioSciences, Inc.
Filing Date: 2025-01-30
Form: 8-K
Item: Item 5.02
Chunk 1
---
with a term expiring at the Company’s 2026 annual meeting of stockholders).

Accordingly, on January 28, 2025, Frank Lee resigned from his position as a Class III director, subject to and conditioned upon his simultaneous reappointment as a Class II director, and Mark Kronenfeld resigned from his position as a Class I director, subject to and conditioned upon his simultaneous reappointment as a Class III director. The Board accepted each of Mr. Lee’s and Dr. Kronenfeld’s resignations and simultaneously reappointed Mr. Lee as a Class II director and Dr. Kronenfeld as a Class III director. The resignation and reappointment of each of Mr. Lee and Dr. Kronenfeld was effected solely for the purpose of reclassifying the members of the Board into three classes consisting of, as nearly as may be possible, one-third of the total number of directors constituting the entire Board, and for all other purposes, each of Mr. Lee’s and Dr. Kronenfeld’s service on the Board is deemed to have continued uninterrupted.

A full list of the directors and their respective term expirations following the Resignations and the reclassifications of Mr. Lee and Dr. Kronenfeld is as follows:

  Class I                             Class II                            Class III                       
  Terms Expiring at the 2027          Terms Expiring at the 2025          Terms Expiring at the 2026      
  Annual Meeting of Stockholders      Annual Meeting of Stockholders      Annual Meeting of Stockholders  
  Laura Brege (Chair)                 Marcelo Bigal                       Abraham Ceesay                  
  Mark Froimson                       Frank Lee                           Christopher Christie            
  Michael Yang                        Alethia Young                       Mark Kronenfeld                 
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────

Committee Reassignments

As a result of the Resignations and the appointment of a new Board Chair described above, on January 28, 2025, effective as of immediately following the effectiveness of the Resignations, the Board restructured the composition of certain committees of the Board, such that the composition of the committees of the Board is now as follows:

  Audit                      Compensation              Nominating, Governance and Sustainability      Science and Technology  
  Committee                  Committee                 Committee                                      Committee               
  Alethia Young (Chair)      Michael Yang (Chair)      Mark Kronenfeld (Chair)                        Marcelo Bigal (Chair)   
  Abraham Ceesay             Abraham Cees